The Valley Desk

NCT04380636 · Interventional trial

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Overall registry status Active not recruiting

Phase 3

Conditions Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov